A Paradigm Shift in Prostate Cancer Treatment: Positive SPLASH Trial Results and POINT Biopharma's Resilient Growth
In the field of oncology, breakthroughs in the treatment of metastatic castration-resistant prostate cancer (mCRPC) have remained a significant challenge. However, recent reports from Lantheus and POINT Biopharma reveal...
Dec 18, 2023
• Major Pharmaceutical Preparations Industry
Clinical Study
actinium-225
